IDH2 and central nervous system cancer: The abnormal accumulation of 2-HG in IDH mutant gliomas and the structural similarities between 2-HG and α-KG provide evidence for the concept that 2-HG might serve as an α-KG antagonist to influence many cellular processes by hydroxylating target proteins utilizing α-KG as a cosubstrate (6, 17).